Vaxess Technologies
Vicki Sato is Professor of Management Practice at Harvard Business School and Professor of the Practice of Molecular and Cellular Biology at Harvard University. Dr. Sato retired as President of Vertex Pharmaceuticals, Inc. in 2005. Prior to joining Vertex, Dr. Sato was Vice President of Research at Biogen, Inc. She brings extensive scientific and business expertise to her role advising young companies and large corporations in the biotechnology and pharmaceutical industries.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Vaxess Technologies
Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. They are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.